French update clinical analyses quality control agenda:
This article was originally published in Clinica
Executive Summary
The French healthcare products safety agency, AFSSAPS, has updated its 2003 calendar of operations for controlling the quality of clinical analyses performed in the country. In June, it is reviewing testing for growth hormones, genetic fingerprinting and for pharmaceutical dosage.